利润表(海尔生物)
上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
一、营业总收入(元) | 1,782,020,224.83 | 1,223,284,970.75 | 686,909,061.52 | 2,280,896,019.23 | 1,826,339,651.43 | 1,270,455,870.90 | 686,668,622.18 |
营业收入(元) | 1,782,020,224.83 | 1,223,284,970.75 | 686,909,061.52 | 2,280,896,019.23 | 1,826,339,651.43 | 1,270,455,870.90 | 686,668,622.18 |
二、营业总成本(元) | 1,468,536,204.53 | 979,179,228.79 | 538,737,974.70 | 1,966,937,346.46 | 1,528,552,037.64 | 1,034,950,299.72 | 557,268,271.77 |
营业成本(元) | 917,519,524.02 | 632,770,459.32 | 346,205,232.18 | 1,125,977,841.74 | 897,464,793.55 | 613,796,745.20 | 336,351,587.42 |
研发费用(元) | 223,579,922.81 | 143,448,942.59 | 77,257,984.27 | 320,636,061.79 | 242,651,271.93 | 157,574,507.09 | 80,011,141.60 |
营业税金及附加(元) | 15,744,301.58 | 11,107,409.56 | 5,757,824.80 | 20,814,451.67 | 15,618,579.09 | 11,684,386.05 | 5,968,665.04 |
销售费用(元) | 211,737,388.26 | 136,298,159.37 | 80,476,077.76 | 339,573,972.29 | 251,803,065.00 | 168,807,126.20 | 80,360,225.34 |
管理费用(元) | 133,850,540.50 | 83,823,829.10 | 41,044,822.78 | 183,467,514.04 | 135,906,685.33 | 93,716,330.74 | 45,572,426.09 |
财务费用(元) | -33,895,472.64 | -28,269,571.15 | -12,003,967.09 | -23,532,495.07 | -14,892,357.26 | -10,628,795.56 | 9,004,226.28 |
其中:利息费用(元) | 2,470,544.38 | 1,758,321.40 | 842,633.79 | 3,511,618.34 | 2,845,834.97 | 1,877,762.20 | 888,122.90 |
其中:利息收入(元) | 37,578,315.51 | 28,268,836.60 | 13,038,215.13 | 35,609,318.83 | 23,938,719.46 | 14,578,931.76 | 6,774,013.30 |
三、其他经营收益 | |||||||
加:公允价值变动收益(元) | -172,721.00 | -1,139,396.68 | 334,520.00 | 2,055,633.22 | -4,125,990.78 | 1,459,949.22 | 319,226.22 |
加:投资收益(元) | 16,606,073.73 | 11,307,110.66 | 3,291,655.49 | 83,033,401.63 | 73,352,937.38 | 58,134,146.01 | 13,015,767.85 |
其中:对联营企业和合营企业的投资收益(元) | 4,506,314.12 | 2,881,437.47 | 995,588.38 | 8,173,158.96 | 3,901,791.08 | 2,065,842.77 | 434,419.11 |
资产处置收益(元) | -124,596.66 | -130,256.06 | -81,512.41 | -1,599,128.48 | -2,062,769.54 | -2,062,769.54 | - |
资产减值损失(元) | -1,755,038.72 | -1,728,897.13 | -12,496.58 | -1,642,752.84 | -1,459,756.76 | -1,520,953.03 | 545,754.01 |
信用减值损失(元) | -19,364,586.03 | -15,489,684.14 | -6,728,018.99 | -2,418,299.47 | -993,675.42 | -431,240.09 | 47,880.39 |
其他收益(元) | 32,131,652.64 | 19,865,772.08 | 9,301,428.65 | 45,013,812.56 | 32,681,352.71 | 20,940,129.35 | 8,013,605.59 |
四、营业利润(元) | 340,804,804.26 | 256,790,390.69 | 154,276,662.98 | 438,401,339.39 | 395,179,711.38 | 312,024,833.10 | 151,342,584.47 |
加:营业外收入(元) | 2,970,937.90 | 2,095,775.24 | 446,140.86 | 3,341,881.01 | 2,512,599.46 | 1,309,461.00 | 677,842.13 |
减:营业外支出(元) | 1,357,245.63 | 17,278.86 | 21,412.15 | 7,252,010.97 | 6,069,846.67 | 6,069,189.79 | 26,898.42 |
五、利润总额(元) | 342,418,496.53 | 258,868,887.07 | 154,701,391.69 | 434,491,209.43 | 391,622,464.17 | 307,265,104.31 | 151,993,528.18 |
减:所得税费用(元) | 23,440,550.64 | 19,731,759.14 | 12,849,152.72 | 22,432,550.67 | 25,976,619.00 | 23,053,475.27 | 12,483,714.67 |
六、净利润(元) | 318,977,945.89 | 239,137,127.93 | 141,852,238.97 | 412,058,658.76 | 365,645,845.17 | 284,211,629.04 | 139,509,813.51 |
(一)按经营持续性分类 | |||||||
持续经营净利润(元) | 318,977,945.89 | 239,137,127.93 | 141,852,238.97 | 412,058,658.76 | 365,645,845.17 | 284,211,629.04 | 139,509,813.51 |
(二)按所有权归属分类 | |||||||
归属于母公司股东的净利润(元) | 309,141,846.32 | 234,342,835.01 | 137,614,697.49 | 406,073,643.93 | 357,201,281.16 | 278,462,841.61 | 137,535,031.82 |
少数股东损益(元) | 9,836,099.57 | 4,794,292.92 | 4,237,541.48 | 5,985,014.83 | 8,444,564.01 | 5,748,787.43 | 1,974,781.69 |
扣除非经常性损益后的净利润(元) | 276,229,678.37 | 211,750,860.17 | 132,888,963.12 | 331,274,893.55 | 293,402,659.23 | 228,979,648.23 | 124,615,241.32 |
七、每股收益 | |||||||
一、基本每股收益(元) | 0.98 | 0.74 | 0.44 | 1.28 | 1.13 | 0.88 | 0.43 |
二、稀释每股收益(元) | 0.98 | 0.74 | 0.44 | 1.28 | 1.13 | 0.88 | 0.43 |
八、其他综合收益(元) | -23,664,262.30 | -24,452,127.42 | 12,754.54 | -43,521,492.11 | -30,515,814.23 | -29,978,428.73 | 98,055.44 |
归属于母公司股东的其他综合收益(元) | -23,664,262.30 | -24,452,127.42 | 12,754.54 | -43,521,492.11 | -30,515,814.23 | -29,978,428.73 | 98,055.44 |
九、综合收益总额(元) | 295,313,683.59 | 214,685,000.51 | 141,864,993.51 | 368,537,166.65 | 335,130,030.94 | 254,233,200.31 | 139,607,868.95 |
归属于母公司所有者的综合收益总额(元) | 285,477,584.02 | 209,890,707.59 | 137,627,452.03 | 362,552,151.82 | 326,685,466.93 | 248,484,412.88 | 137,633,087.26 |
归属于少数股东的综合收益总额(元) | 9,836,099.57 | 4,794,292.92 | 4,237,541.48 | 5,985,014.83 | 8,444,564.01 | 5,748,787.43 | 1,974,781.69 |
公告日期 | 2024-10-30 | 2024-08-23 | 2024-04-26 | 2024-03-28 | 2023-10-27 | 2023-08-30 | 2023-04-26 |
审计意见(境内) | 标准无保留意见 | ||||||
原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
上市前/上市后 |
报表类型 |
一、营业总收入(元) |
营业收入(元) |
二、营业总成本(元) |
营业成本(元) |
研发费用(元) |
营业税金及附加(元) |
销售费用(元) |
管理费用(元) |
财务费用(元) |
其中:利息费用(元) |
其中:利息收入(元) |
三、其他经营收益 |
加:公允价值变动收益(元) |
加:投资收益(元) |
其中:对联营企业和合营企业的投资收益(元) |
资产处置收益(元) |
资产减值损失(元) |
信用减值损失(元) |
其他收益(元) |
四、营业利润(元) |
加:营业外收入(元) |
减:营业外支出(元) |
五、利润总额(元) |
减:所得税费用(元) |
六、净利润(元) |
(一)按经营持续性分类 |
持续经营净利润(元) |
(二)按所有权归属分类 |
归属于母公司股东的净利润(元) |
少数股东损益(元) |
扣除非经常性损益后的净利润(元) |
七、每股收益 |
一、基本每股收益(元) |
二、稀释每股收益(元) |
八、其他综合收益(元) |
归属于母公司股东的其他综合收益(元) |
九、综合收益总额(元) |
归属于母公司所有者的综合收益总额(元) |
归属于少数股东的综合收益总额(元) |
公告日期 |
审计意见(境内) |
原始财报文件下载 |
Showing 1 to 44 of 44 entries